{"id":49393,"date":"2022-10-07T18:01:39","date_gmt":"2022-10-07T16:01:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/"},"modified":"2022-10-07T18:01:39","modified_gmt":"2022-10-07T16:01:39","slug":"global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/","title":{"rendered":"Global Wound Closure Devices Pipeline Report 2022 &#8211; Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5625048\/wound-closure-devices-pipeline-report-including?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=f44bph&amp;utm_campaign=1759785+-+Global+Wound+Closure+Devices+Pipeline+Report+2022+-+Featuring+Abyrx%2C+ACell%2C+Acro+Biomedical+and+Actamax+Surgical+Materials+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Wound Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221007005415\/en\/1595698\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221007005415\/en\/1595698\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report provides comprehensive information about the Wound Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.\n<\/p>\n<p>\nWound closure devices are used to close wounds that occur due to injuries or surgical procedures.\n<\/p>\n<p>\nNote: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.\n<\/p>\n<p>\n<strong>Scope<\/strong>\n<\/p>\n<ul>\n<li>\nExtensive coverage of the Wound Closure Devices under development\n<\/li>\n<li>\nThe report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities\n<\/li>\n<li>\nThe report reviews the major players involved in the development of Wound Closure Devices and list all their pipeline projects\n<\/li>\n<li>\nThe coverage of pipeline products based on various stages of development ranging from Early Development to Approved \/ Issued stage\n<\/li>\n<li>\nThe report provides key clinical trial data of ongoing trials specific to pipeline products\n<\/li>\n<li>\nRecent developments in the segment \/ industry\n<\/li>\n<\/ul>\n<p>\n<strong>Reasons to Buy<\/strong>\n<\/p>\n<p>\nThe report enables you to:\n<\/p>\n<ul>\n<li>\nFormulate significant competitor information, analysis, and insights to improve R&amp;D strategies\n<\/li>\n<li>\nIdentify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage\n<\/li>\n<li>\nIdentify and understand important and diverse types of Wound Closure Devices under development\n<\/li>\n<li>\nDevelop market-entry and market expansion strategies\n<\/li>\n<li>\nPlan mergers and acquisitions effectively by identifying major players with the most promising pipeline\n<\/li>\n<li>\nIn-depth analysis of the product&#8217;s current stage of development, territory and estimated launch date\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Table of Contents<\/strong>\n<\/p>\n<p>\n<strong>2 Introduction<\/strong>\n<\/p>\n<p>\n<strong>3 Products under Development<\/strong>\n<\/p>\n<p>\n3.1 Wound Closure Devices &#8211; Pipeline Products by Stage of Development\n<\/p>\n<p>\n3.2 Wound Closure Devices &#8211; Pipeline Products by Segment\n<\/p>\n<p>\n3.3 Wound Closure Devices &#8211; Pipeline Products by Territory\n<\/p>\n<p>\n3.4 Wound Closure Devices &#8211; Pipeline Products by Regulatory Path\n<\/p>\n<p>\n3.5 Wound Closure Devices &#8211; Pipeline Products by Estimated Approval Date\n<\/p>\n<p>\n3.6 Wound Closure Devices &#8211; Ongoing Clinical Trials\n<\/p>\n<p>\n<strong>4 Wound Closure Devices &#8211; Pipeline Products under Development by Companies<\/strong>\n<\/p>\n<p>\n4.1 Wound Closure Devices Companies &#8211; Pipeline Products by Stage of Development\n<\/p>\n<p>\n4.2 Wound Closure Devices &#8211; Pipeline Products by Stage of Development\n<\/p>\n<p>\n<strong>5 Wound Closure Devices Companies and Product Overview<\/strong>\n<\/p>\n<p>\n<strong>6 Wound Closure Devices &#8211; Recent Developments<\/strong>\n<\/p>\n<p>\n<strong>7 Appendix<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\n3-D Matrix Ltd\n<\/li>\n<li>\nAbyrx, Inc.\n<\/li>\n<li>\nACell Inc\n<\/li>\n<li>\nAcro Biomedical Co Ltd\n<\/li>\n<li>\nActamax Surgical Materials LLC\n<\/li>\n<li>\nAdhesys Medical GmbH\n<\/li>\n<li>\nAdvanced Biotech Products Pvt Ltd\n<\/li>\n<li>\nAdvanced Medical Solutions Group plc\n<\/li>\n<li>\nAFYX Therapeutics A\/S\n<\/li>\n<li>\nAlafair Biosciences Inc\n<\/li>\n<li>\nAlbert Ludwig University of Freiburg\n<\/li>\n<li>\nAleo BME Inc\n<\/li>\n<li>\nAlumend LLC\n<\/li>\n<li>\nAngiotech Pharmaceuticals Inc\n<\/li>\n<li>\nAnika Therapeutics Inc\n<\/li>\n<li>\nAPRUS Bio-Medical Innovations Pvt Ltd\n<\/li>\n<li>\nARC Medical Devices Inc\n<\/li>\n<li>\nArch Therapeutics Inc\n<\/li>\n<li>\nArizona State University\n<\/li>\n<li>\nArtivion Inc\n<\/li>\n<li>\nAura Medsystems, Inc.\n<\/li>\n<li>\nBaroStitch\n<\/li>\n<li>\nBaxter Healthcare Corp\n<\/li>\n<li>\nBaxter International Inc\n<\/li>\n<li>\nBayer AG\n<\/li>\n<li>\nBergen Medical Products Inc\n<\/li>\n<li>\nBeth Israel Deaconess Medical Center\n<\/li>\n<li>\nBioActive Polymers in Lund AB\n<\/li>\n<li>\nBioDevek Inc\n<\/li>\n<li>\nBiomedica Management Corp\n<\/li>\n<li>\nBiom&#8217;Up SAS\n<\/li>\n<li>\nBNC Korea Co Ltd\n<\/li>\n<li>\nBorayer Biotechnology Co Ltd\n<\/li>\n<li>\nBoston University\n<\/li>\n<li>\nCalmare Therapeutics Inc\n<\/li>\n<li>\nCardioCommand Inc\n<\/li>\n<li>\nCellphire Inc\n<\/li>\n<li>\nCeramicos Para Aplicacoes Medicas SA\n<\/li>\n<li>\nClemson University\n<\/li>\n<li>\nCohera Medical Inc\n<\/li>\n<li>\nColumbia University\n<\/li>\n<li>\nCovalent Medical, Inc. (Inactive)\n<\/li>\n<li>\nCovalon Technologies Ltd\n<\/li>\n<li>\nCovidien Ltd\n<\/li>\n<li>\nCR Bard Inc\n<\/li>\n<li>\nCresilon Inc\n<\/li>\n<li>\nDepartment of Biomedical Engineering Columbia University\n<\/li>\n<li>\nDSM Biomedical BV\n<\/li>\n<li>\nDuke University\n<\/li>\n<li>\nEidgenossische Materialprufungs- und Forschungsanstalt\n<\/li>\n<li>\nElastagen Pty Ltd\n<\/li>\n<li>\nEmory University\n<\/li>\n<li>\nEndomedix Incorporated\n<\/li>\n<li>\nEntegrion Inc\n<\/li>\n<li>\nEthicon Endo-Surgery Inc\n<\/li>\n<li>\nEthicon US LLC\n<\/li>\n<li>\nETX Pharma Inc\n<\/li>\n<li>\nFzioMed Inc\n<\/li>\n<li>\nGamma Diagnostics Inc\n<\/li>\n<li>\nGATT Technologies BV\n<\/li>\n<li>\nGenzyme Corp\n<\/li>\n<li>\nHaemostatix Ltd\n<\/li>\n<li>\nHangzhou Kangji Medical Instrument Co Ltd\n<\/li>\n<li>\nHemostasis LLC\n<\/li>\n<li>\nHLL Lifecare Ltd\n<\/li>\n<li>\nHydroGlaze BV\n<\/li>\n<li>\nHyperBranch Medical Technology Inc\n<\/li>\n<li>\nIchor Sciences LLC\n<\/li>\n<li>\nInnocoll Technologies Ltd (Inactive)\n<\/li>\n<li>\nInstitute of Molecular Biology of Parana\n<\/li>\n<li>\nInVivo Therapeutics Corp\n<\/li>\n<li>\nIonMed Ltd.\n<\/li>\n<li>\nJiangxi Boenruier Biotechnology Co Ltd\n<\/li>\n<li>\nJohns Hopkins University\n<\/li>\n<li>\nKeratin Biosciences Inc\n<\/li>\n<li>\nKollodis BioSciences Inc\n<\/li>\n<li>\nKuros Biosciences AG\n<\/li>\n<li>\nKytogenics Pharmaceuticals Inc\n<\/li>\n<li>\nLap IQ Inc\n<\/li>\n<li>\nLaser Tissue Welding, Inc.\n<\/li>\n<li>\nLatch Medical Ltd\n<\/li>\n<li>\nLeader Biomedical Europe BV\n<\/li>\n<li>\nLenvitz Medical Solutions Pvt Ltd\n<\/li>\n<li>\nLife Care Medical Devices Ltd\n<\/li>\n<li>\nLuna Innovations Inc\n<\/li>\n<li>\nMagen OrthoMed Ltd\n<\/li>\n<li>\nMassachusetts Institute of Technology\n<\/li>\n<li>\nMaxigen Biotech Inc\n<\/li>\n<li>\nMedcura Inc\n<\/li>\n<li>\nMedisse BV (Inactive)\n<\/li>\n<li>\nMeril Life Sciences Pvt Ltd\n<\/li>\n<li>\nMLM Biologics Inc\n<\/li>\n<li>\nN8 Medical LLC\n<\/li>\n<li>\nNanyang Technological University\n<\/li>\n<li>\nNational University of Ireland Galway\n<\/li>\n<li>\nNational University of Singapore\n<\/li>\n<li>\nNorthwestern University\n<\/li>\n<li>\nNurami Medical Ltd\n<\/li>\n<li>\nOptMed, Inc.\n<\/li>\n<li>\nPetVivo Holdings Inc\n<\/li>\n<li>\nPharming Group NV\n<\/li>\n<li>\nPolyganics BV\n<\/li>\n<li>\nPolyNovo Biomaterials Pty Ltd\n<\/li>\n<li>\nProgress and Health Foundation\n<\/li>\n<li>\nProtege Biomedical LLC\n<\/li>\n<li>\nProtein Polymer Technologies Inc (Inactive)\n<\/li>\n<li>\nPurdue University\n<\/li>\n<li>\nRadiation Monitoring Devices Inc\n<\/li>\n<li>\nRegenics AS\n<\/li>\n<li>\nResorba GmbH\n<\/li>\n<li>\nRice University\n<\/li>\n<li>\nRutgers The State University of New Jersey\n<\/li>\n<li>\nSamyang Biopharmaceuticals Corp\n<\/li>\n<li>\nSanofi Biosurgery Inc\n<\/li>\n<li>\nSea Run Holdings Inc\n<\/li>\n<li>\nSealantis Ltd.\n<\/li>\n<li>\nSeikagaku Corp\n<\/li>\n<li>\nSeraffix Ltd\n<\/li>\n<li>\nShanghai Haohai Biological Technology Co Ltd\n<\/li>\n<li>\nSporogenics Pte Ltd\n<\/li>\n<li>\nSt Teresa Medical Inc\n<\/li>\n<li>\nStanford University\n<\/li>\n<li>\nStarling Surgical\n<\/li>\n<li>\nSTB Lifesaving Technologies\n<\/li>\n<li>\nSurgical Energetics LLC\n<\/li>\n<li>\nSurgical Sealants, Inc.\n<\/li>\n<li>\nTectum\n<\/li>\n<li>\nTeijin Pharma Ltd\n<\/li>\n<li>\nTetratherix Pty Ltd\n<\/li>\n<li>\nTexas A&amp;M University\n<\/li>\n<li>\nThe Medicines Co\n<\/li>\n<li>\nTheraCell Inc\n<\/li>\n<li>\nTherus Corporation\n<\/li>\n<li>\nThrombotargets Corp\n<\/li>\n<li>\nTissium SA\n<\/li>\n<li>\nToray Medical Co Ltd\n<\/li>\n<li>\nTribos LLC\n<\/li>\n<li>\nTricol Biomedical Inc\n<\/li>\n<li>\nTYBR Health Inc\n<\/li>\n<li>\nUnited Health Products, Inc.\n<\/li>\n<li>\nUniversity of Akron\n<\/li>\n<li>\nUniversity of Grenoble Alpes\n<\/li>\n<li>\nUniversity of Kansas\n<\/li>\n<li>\nUniversity of Minnesota\n<\/li>\n<li>\nUniversity of North Carolina at Chapel Hill\n<\/li>\n<li>\nUniversity of Pennsylvania\n<\/li>\n<li>\nUniversity of Toledo\n<\/li>\n<li>\nVirginia Commonwealth University\n<\/li>\n<li>\nWoundZipper Inc\n<\/li>\n<li>\nXcede Technologies Inc\n<\/li>\n<li>\nYale University\n<\/li>\n<li>\nYantai Zhenghai Biological Technology Co Ltd\n<\/li>\n<li>\nZ-Medica LLC\n<\/li>\n<li>\nZSX Medical LLC\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5625048\/wound-closure-devices-pipeline-report-including?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=f44bph&amp;utm_campaign=1759785+-+Global+Wound+Closure+Devices+Pipeline+Report+2022+-+Featuring+Abyrx%2C+ACell%2C+Acro+Biomedical+and+Actamax+Surgical+Materials+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/itkuom<\/a>\n<\/p>\n<p>\nSource: GlobalData\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;t&#x6f;&#58;&#x70;&#x72;e&#x73;&#115;&#64;&#x72;&#101;&#x73;&#101;a&#x72;&#99;h&#x61;&#110;&#x64;&#109;a&#x72;&#107;&#x65;&#x74;s&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#101;&#115;s&#x40;&#x72;&#x65;&#115;&#101;a&#x72;&#x63;&#x68;&#97;&#110;d&#x6d;&#x61;&#x72;&#107;&#101;t&#x73;&#x2e;&#x63;&#111;m<\/a>\n<\/p>\n<p>\nFor E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Wound Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides comprehensive information about the Wound Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49393","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Wound Closure Devices Pipeline Report 2022 - Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Wound Closure Devices Pipeline Report 2022 - Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Wound Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides comprehensive information about the Wound Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-07T16:01:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221007005415\/en\/1595698\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Wound Closure Devices Pipeline Report 2022 &#8211; Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-07T16:01:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/\"},\"wordCount\":953,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005415\\\/en\\\/1595698\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Wound Closure Devices Pipeline Report 2022 - Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005415\\\/en\\\/1595698\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-07T16:01:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005415\\\/en\\\/1595698\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005415\\\/en\\\/1595698\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Wound Closure Devices Pipeline Report 2022 &#8211; Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Wound Closure Devices Pipeline Report 2022 - Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Wound Closure Devices Pipeline Report 2022 - Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Wound Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides comprehensive information about the Wound Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-07T16:01:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221007005415\/en\/1595698\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Wound Closure Devices Pipeline Report 2022 &#8211; Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-10-07T16:01:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/"},"wordCount":953,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221007005415\/en\/1595698\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/","name":"Global Wound Closure Devices Pipeline Report 2022 - Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221007005415\/en\/1595698\/21\/logo.jpg","datePublished":"2022-10-07T16:01:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221007005415\/en\/1595698\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221007005415\/en\/1595698\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-wound-closure-devices-pipeline-report-2022-featuring-abyrx-acell-acro-biomedical-and-actamax-surgical-materials-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Wound Closure Devices Pipeline Report 2022 &#8211; Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49393"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49393\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}